{
  "paper_metadata": {
    "pmid": "37064128",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on BRCA2 variants, including clinical significance, penetrance data, and individual records."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.2307delT",
      "protein_notation": "p.I770Ffs*2",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 19,
        "demographics": "Patients with gynecological cancer, specific demographics not detailed.",
        "phenotype": "Most mutations found in patients with ovarian cancer (OC)."
      },
      "penetrance_data": {
        "total_carriers_observed": 19,
        "affected_count": 11,
        "unaffected_count": 8,
        "uncertain_count": null,
        "penetrance_percentage": 57.89,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "BRCA2 mutation c.2307delT p.I770Ffs*2 was identified as a hotspot among Chinese patients.",
        "assays": []
      },
      "segregation_data": "The frequency of germline BRCA2 mutations was higher than somatic mutations.",
      "population_frequency": null,
      "evidence_level": "Moderate evidence based on frequency in patients with OC.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "No specific functional assays or in vitro studies mentioned.",
      "key_quotes": [
        "A new mutation hotspot in BRCA2 (I770) was firstly discovered among Chinese patients with gynecological cancer.",
        "Moreover, the frequency of germline BRCA2 mutations (11/19, 57.89%) was higher than that of BRCA1 mutations."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding BRCA2 variants were extracted successfully."
  }
}